RENAISSANCE TECHNOLOGIES LLC
Position in ACHV — Achieve Life Sciences, Inc.
CIK 1037389
NEW YORK, NY
Position in ACHV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$82,178
-$675,548 QoQ
Shares Held
27,952
-81.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 81 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,447,997,584 across 326 Biotechnology names. ACHV ranks #293 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in ACHV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,178 | 27,952 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $757,726 | 152,460 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $978,906 | 310,764 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $234,655 | 87,886 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $215,283 | 61,160 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $169,976 | 35,860 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $117,782 | 25,060 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $48,685 | 10,700 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $44,908 | 10,900 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $95,030 | 22,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $205,524 | 39,600 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $282,880 | 41,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $96,040 | 39,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $127,710 | 38,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $193,736 | 39,700 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $190,764 | 25,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $185,164 | 23,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $192,100 | 22,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $691,100 | 76,960 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $255,466 | 22,061 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||